We also examined the effect of Wnt-C59 treatment on FOXM1 expression in GBM and GSC cell lines and found that FOXM1 expression decreased in the presence of Wnt-C59 both in vitro and in vivo. The gene discussed is FOXM1; the disease is glioblastoma.